Although lymph node metastasis shows a positive correlation with tumor burden in HR+ breast cancer patients,44 we did not find a significant difference in tumor size and tumor grade when comparing patients with a detectable or undetectable circulating antitumor CD8 T cell response. The gene discussed is CD8A; the disease is breast carcinoma.